Skip to content

Clinical trials

Phase 3 Parasomnias trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parasomnias Phase: Phase 3 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20075
20082
20091
20101
20111
20132
20201
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Active, not recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
Avadel1
Lindner Center of HOPE1
M.D. Anderson Cancer Center1
Neurim Pharmaceuticals Ltd.1
Pfizer1
St. Jude Children's Research Hospital1
Takeda1
University of California, Berkeley1
University of Texas Southwestern Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parasomnias16
Sleep Initiation and Maintenance Disorders6
Sleep Wake Disorders5
Autism Spectrum Disorder2
Bipolar Disorder2
Disorders of Excessive Somnolence2
Angelman Syndrome1
Anxiety Disorders1
Apnea1
Breast Neoplasms1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.